Delivery of a First-in-Class miR-10b Antagomir to Treat Metastatic Cancer:The Long Winding Road from Pre-Clinical Development to Initial Clinical Experience
Conference Dates
April 4 - 8, 2024
Abstract
Please click Additional Files below to see the full abstract
Recommended Citation
Zdravka Medarova, "Delivery of a First-in-Class miR-10b Antagomir to Treat Metastatic Cancer:The Long Winding Road from Pre-Clinical Development to Initial Clinical Experience" in "Delivery Of Nucleic Acid Therapeutics II: Biology, Engineering And Development", Steven F. Dowdy, UCSD School of Medicine, USA; Laura Sepp-Lorenzino, Intellia Therapeutics, USA; Matt Stanton, Generation Bio, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/nucleic_acid_therapeutics_ii/42
7.pdf (189 kB)
COinS